Francis Peterson, PhD

Publications

• Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model.

  (Getschman AE, Imai Y, Larsen O, Peterson FC, Wu X, Rosenkilde MM, Hwang ST, Volkman BF.) Proc Natl Acad Sci U S A. 2017 11 21;114(47):12460-12465.

• A Rationally Designed Agonist Defines Subfamily IIIA Abscisic Acid Receptors As Critical Targets for Manipulating Transpiration.

  (Vaidya AS, Peterson FC, Yarmolinsky D, Merilo E, Verstraeten I, Park SY, Elzinga D, Kaundal A, Helander J, Lozano-Juste J, Otani M, Wu K, Jensen DR, Kollist H, Volkman BF, Cutler SR.) ACS Chem Biol. 2017 11 17;12(11):2842-2848.

• CCR7 Sulfotyrosine Enhances CCL21 Binding.

  (Phillips AJ, Taleski D, Koplinski CA, Getschman AE, Moussouras NA, Richard AM, Peterson FC, Dwinell MB, Volkman BF, Payne RJ, Veldkamp CT.) Int J Mol Sci. 2017 Aug 25;18(9).

• Structure and Dimerization of IreB, a Negative Regulator of Cephalosporin Resistance in Enterococcus faecalis.

  (Hall CL, Lytle BL, Jensen D, Hoff JS, Peterson FC, Volkman BF, Kristich CJ.) J Mol Biol. 2017 07 21;429(15):2324-2336.

• Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.

  (Ziarek JJ, Kleist AB, London N, Raveh B, Montpas N, Bonneterre J, St-Onge G, DiCosmo-Ponticello CJ, Koplinski CA, Roy I, Stephens B, Thelen S, Veldkamp CT, Coffman FD, Cohen MC, Dwinell MB, Thelen M, Peterson FC, Heveker N, Volkman BF.) Sci Signal. 2017 Mar 21;10(471).

• NMR Structure of the C-Terminal Transmembrane Domain of the HDL Receptor, SR-BI, and a Functionally Relevant Leucine Zipper Motif.

  (Chadwick AC, Jensen DR, Hanson PJ, Lange PT, Proudfoot SC, Peterson FC, Volkman BF, Sahoo D.) Structure. 2017 03 07;25(3):446-457.

• Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.

  (Cimbro R, Peterson FC, Liu Q, Guzzo C, Zhang P, Miao H, Van Ryk D, Ambroggio X, Hurt DE, De Gioia L, Volkman BF, Dolan MA, Lusso P.) EBioMedicine. 2016 Aug;10:45-54.

• Structure-Based Identification of Novel Ligands Targeting Multiple Sites within a Chemokine-G-Protein-Coupled-Receptor Interface.

  (Smith EW, Nevins AM, Qiao Z, Liu Y, Getschman AE, Vankayala SL, Kemp MT, Peterson FC, Li R, Volkman BF, Chen Y.) J Med Chem. 2016 05 12;59(9):4342-51.

• Correction to Binding of Crumbs to the Par-6 CRIB-PDZ Module Is Regulated by Cdc42.

  (Whitney DS, Peterson FC, Kittell AW, Egner JM, Prehoda KE, Volkman BF.) Biochemistry. 2016 Apr 05;55(13):2063.

• Binding of Crumbs to the Par-6 CRIB-PDZ Module Is Regulated by Cdc42.

  (Whitney DS, Peterson FC, Kittell AW, Egner JM, Prehoda KE, Volkman BF.) Biochemistry. 2016 Mar 15;55(10):1455-61.

• Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer.

  (Fox JC, Tyler RC, Peterson FC, Dyer DP, Zhang F, Linhardt RJ, Handel TM, Volkman BF.) Biochemistry. 2016 Mar 01;55(8):1214-25.

• Production of Recombinant Chemokines and Validation of Refolding.

  (Veldkamp CT, Koplinski CA, Jensen DR, Peterson FC, Smits KM, Smith BL, Johnson SK, Lettieri C, Buchholz WG, Solheim JC, Volkman BF.) Methods Enzymol. 2016;570:539-65.